Effect of Gefitinib in the Treatment of EGFR Positive Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer Patients and Its Influence on EGFR and P-Akt

YUAN Hui; XU Yang; ZHANG Juan

doi:10.14033/j.cnki.cfmr.2023.01.011

Home>Articles>Effect of Gefitinib in the Treatment of EGFR Positive Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer Patients and Its Influence on EGFR and P-Akt

DOI: 10.14033/j.cnki.cfmr.2023.01.011

Effect of Gefitinib in the Treatment of EGFR Positive Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer Patients and Its Influence on EGFR and P-Akt

YUAN Hui

XU Yang

ZHANG Juan

Machine-generated Keywords：

Publication Date：2023-01-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 45-48 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2023,21(1)